Deal round-up 18/04

Ampal-American Israel, Benchmark and Royal Bank Ventures all make investments and Celexa is hot property for Aberdeen Asset Management.

Aberdeen selects Celexa

Aberdeen Asset Management has acquired Celexa Group, a Sweden-based European property fund management group for £16.5m.

Celexa is being bought from Alecta, a Scandinavian pension company, for £1.4m in cash and about 2.9m new shares.

Celexa holds assets across Europe and manages a specialist pan-European property fund.

The Celexa deal brings Aberdeen’s managed property assets to more than £4bn. Last year, Aberdeen bought the property fund management business of Barclays Global Investors.

Third round for ShellCase

ShellCase has raised $20m in its third private placement. The Israeli company develops chip-sized packaging technology for semiconductors.

The round was led by previous investors, including Ampal-American Israel, Clal Electronics and Israel Infinity Venture Capital Fund.

New investors include GE Asset Management, Motorola Ventures, SG Cowen Ventures and Schott Glass.

ShellCase will use the money will be used to expand its US presence.

ShellCase is publicly traded on the Canadian Venture Exchange. The company has raised a total of $25.1m in equity financing.

Lycium bags $2m from Benchmark

Lycium Networks, an Israeli firm developing chips for voice and data convergence, says it has received $2m of seed funding from Benchmark Capital.

Benchmark launched a $200m fund in November to finance early-stage Israeli high-tech companies.

RBS leads £500,000 second round for Web4Test

Royal Bank Ventures, the technology venture arm of the Royal Bank of Scotland (RBS), has invested £500,000 in Web4Test.

Web4Test is an Edinburgh-based online learning company that was spun out of Heriot-Watt university a year ago.

Last year, RBS provided Web4Test with initial backing of £1m.

Royal Bank Ventures was launched this January. It aims to make investments of between £1m and £10m in European technology firms.